Literature DB >> 1666284

Stepwise activation mechanisms of the precursors of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin).

H Nagase1, K Suzuki, J J Enghild, G Salvesen.   

Abstract

Two zymogens of matrix metalloproteinases (MMPs), proMMP-1 (tissue procollagenase) and proMMP-3 (prostromelysin) were isolated from the culture medium of human rheumatoid synovial fibroplasts and their activation mechanisms by proteinases and 4-aminophenylmercuric acetate (APMA) were studied by kinetic and sequence analyses. Both zymogens were activated by unique stepwise activation mechanisms through which sequential processing events occur in the propeptide regions. The initial cleavage sites attacked by activator proteinases are located in the middle of the propeptides at Glu33-Lys-Arg-Arg-Asn37 in proMMP-1 and Phe34-Val-Arg-Arg-Lys-Asp39 in proMMP-3. The initial products of proMMP-1 generated by proteinases then undergo further autocleavage of the Thr64-Leu65 bond. The treatment of proMMP-1 and proMMP-3 with APMA results in the intramolecular cleavage of the Val67-Met68 and Glu68-Val69 bonds, respectively. The removal of a portion of propeptides results in conformational changes around the Gln80-Phe81 and His82-Phe83 bonds in respective intermediates of MMP-1 and MMP-3 and render them to rapid specific cleavage by MMP-3 to generate stable, fully active enzymes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1666284

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  15 in total

1.  Activation of neutrophil collagenase in periodontitis.

Authors:  R Romanelli; S Mancini; C Laschinger; C M Overall; J Sodek; C A McCulloch
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.

Authors:  A R Khan; M N James
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

3.  Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1.

Authors:  William H Nugent; Nikita Mishra; Jerome F Strauss; Scott W Walsh
Journal:  Reprod Sci       Date:  2015-10-04       Impact factor: 3.060

4.  Action of metalloproteinases on porcine dentin mineralization.

Authors:  M Fukae; T Tanabe; M Yamada
Journal:  Calcif Tissue Int       Date:  1994-12       Impact factor: 4.333

5.  Enhancement of scleral macromolecular permeability with prostaglandins.

Authors:  R N Weinreb
Journal:  Trans Am Ophthalmol Soc       Date:  2001

6.  Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness.

Authors:  Scott S Wagers; Ryan J Norton; Lisa M Rinaldi; Jason H T Bates; Burton E Sobel; Charles G Irvin
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 7.  Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking.

Authors:  Charles A Galea; Hai M Nguyen; K George Chandy; Brian J Smith; Raymond S Norton
Journal:  Cell Mol Life Sci       Date:  2013-08-03       Impact factor: 9.261

8.  Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.

Authors:  J W Becker; A I Marcy; L L Rokosz; M G Axel; J J Burbaum; P M Fitzgerald; P M Cameron; C K Esser; W K Hagmann; J D Hermes
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

9.  H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption.

Authors:  K Ohishi; N Fujita; Y Morinaga; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

10.  The molecular basis of urokinase inhibition: from the nonempirical analysis of intermolecular interactions to the prediction of binding affinity.

Authors:  Renata Grzywa; Edyta Dyguda-Kazimierowicz; Marcin Sieńczyk; Mikołaj Feliks; W Andrzej Sokalski; Józef Oleksyszyn
Journal:  J Mol Model       Date:  2007-03-20       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.